Patents Assigned to Beijing Youan Hospital, Captical Medical University
  • Publication number: 20190345559
    Abstract: Disclosed is a DNA methylation signature in Peripheral Blood Mononuclear cells (PBMC) for predicting hepatocellular carcinoma (HCC) stages and chronic hepatitis, which is CG IDs. This invention also disclosed kits and uses for the DNA methylation signature.
    Type: Application
    Filed: June 23, 2016
    Publication date: November 14, 2019
    Applicants: Beijing Youan Hospital, Captical Medical University
    Inventors: Moshe SZYF, Ning LI, Yonghong ZHANG, Sophie PETROPOULOS